Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Benign Neoplasms, Brain

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Benign Neoplasms, Brain in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saitoh, K1
Mikuni, M1
Ikeda, M1
Yamazaki, C1
Tomita, U1
Takahashi, K1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Benign Neoplasms, Brain

ArticleYear
Serotonin-induced 5-HT1A receptor desensitization in C6BU-1 glioma cells transfected with 5-HT1A receptor gene.
    Neuroscience letters, 1995, Oct-27, Volume: 199, Issue:3

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Brain Neoplasms; Colforsin; Cyclic AMP; Dose-Respon

1995